South Korea
· Delayed Price · Currency is KRW METACARE CO. Statistics
Total Valuation
METACARE CO. has a market cap or net worth of KRW 58.33 billion. The enterprise value is 95.68 billion.
| Market Cap | 58.33B |
| Enterprise Value | 95.68B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
METACARE CO. has 164.78 million shares outstanding. The number of shares has increased by 30.65% in one year.
| Current Share Class | 164.78M |
| Shares Outstanding | 164.78M |
| Shares Change (YoY) | +30.65% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.01% |
| Float | 84.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.74 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 41.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 152.58, with an EV/FCF ratio of -1.48.
| EV / Earnings | -22.06 |
| EV / Sales | 4.49 |
| EV / EBITDA | 152.58 |
| EV / EBIT | n/a |
| EV / FCF | -1.48 |
Financial Position
The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.44.
| Current Ratio | 6.03 |
| Quick Ratio | 5.20 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 12.38 |
| Debt / FCF | -0.79 |
| Interest Coverage | 1.84 |
Financial Efficiency
Return on equity (ROE) is -9.67% and return on invested capital (ROIC) is 0.73%.
| Return on Equity (ROE) | -9.67% |
| Return on Assets (ROA) | 0.71% |
| Return on Invested Capital (ROIC) | 0.73% |
| Return on Capital Employed (ROCE) | 0.99% |
| Revenue Per Employee | 666.11M |
| Profits Per Employee | -135.57M |
| Employee Count | 32 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 12.37 |
Taxes
In the past 12 months, METACARE CO. has paid 78.31 million in taxes.
| Income Tax | 78.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.78% in the last 52 weeks. The beta is 0.66, so METACARE CO.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -28.78% |
| 50-Day Moving Average | 333.68 |
| 200-Day Moving Average | 329.74 |
| Relative Strength Index (RSI) | 48.28 |
| Average Volume (20 Days) | 1,095,527 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, METACARE CO. had revenue of KRW 21.32 billion and -4.34 billion in losses. Loss per share was -27.72.
| Revenue | 21.32B |
| Gross Profit | 8.38B |
| Operating Income | 1.68B |
| Pretax Income | -11.29B |
| Net Income | -4.34B |
| EBITDA | 4.16B |
| EBIT | 1.68B |
| Loss Per Share | -27.72 |
Balance Sheet
The company has 14.14 billion in cash and 51.49 billion in debt, giving a net cash position of -37.35 billion or -226.68 per share.
| Cash & Cash Equivalents | 14.14B |
| Total Debt | 51.49B |
| Net Cash | -37.35B |
| Net Cash Per Share | -226.68 |
| Equity (Book Value) | 115.72B |
| Book Value Per Share | 702.26 |
| Working Capital | 22.99B |
Cash Flow
In the last 12 months, operating cash flow was 1.41 billion and capital expenditures -66.20 billion, giving a free cash flow of -64.79 billion.
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -66.20B |
| Free Cash Flow | -64.79B |
| FCF Per Share | -393.20 |
Margins
Gross margin is 39.32%, with operating and profit margins of 7.88% and -20.35%.
| Gross Margin | 39.32% |
| Operating Margin | 7.88% |
| Pretax Margin | -52.99% |
| Profit Margin | -20.35% |
| EBITDA Margin | 19.50% |
| EBIT Margin | 7.88% |
| FCF Margin | n/a |
Dividends & Yields
METACARE CO. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.44% |
| FCF Yield | -111.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2014. It was a reverse split with a ratio of 0.1.
| Last Split Date | Feb 13, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
METACARE CO. has an Altman Z-Score of 0.36 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.36 |
| Piotroski F-Score | 5 |